Executive Summary
The 13 filings in this MCA Merger & Acquisition Tracker digest reveal a market dominated by strategic consolidation and capital deployment into high-growth niches, with a clear preference for non-cash structures and related-party transactions.
A standout theme is the aggressive pursuit of growth in the premium craft beverage sector, exemplified by United Spirits' two investments in Nuvola Spirits, which saw a staggering 821% YoY revenue surge, though from a minuscule base. Conversely, the period comparisons for Godrej Pet Care highlight the volatility of early-stage ventures, with a 37% revenue decline in FY25 before a recovery. The most material development is Samvardhana Motherson's completion of its large-scale acquisition of an 81% stake in Yutaka Giken, a cross-border deal that underscores a trend of Indian companies acquiring global assets for technology and market access. Insider activity is notably absent across filings, but capital allocation patterns are clear: companies are using share swaps (Tejassvi Aaharam), bonus preference shares (Siyaram Silk), and rights issues (Godrej Pet Care) to fund acquisitions or reward shareholders, indicating a preference for preserving cash. The overall sentiment is cautiously positive, with several high-materiality deals (Samvardhana Motherson, Emcure, Crest Ventures) moving forward, but tempered by the small scale of many transactions and the lack of immediate financial impact from internal restructurings.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Merger Acquisition MCA Regulatory Filings digest from July 21, 2026.
Investment Signals (10)
- Samvardhana Motherson International ↓ (BULLISH)▲
Completed acquisition of 81% stake in Yutaka Giken (YGCL) for global expansion. The deal, initially disclosed in Aug 2025, closed on schedule (Q2 FY2026-27), demonstrating strong execution. Post-acquisition, YGCL's shareholding is 81% held by MGI BV and 19% by Honda Motor, providing a strategic partnership.
- United Spirits ↓ (BULLISH)▲
Invested INR 2.69 Cr for a 10.08% stake in Nuvola Spirits, which has a high-growth trajectory (revenue from INR 0.38 Cr in FY25 to INR 3.50 Cr in FY26, an 821% YoY increase). The deal includes an option to acquire remaining shares upon milestone achievement, offering a potential high-return exit or full acquisition.
- Tejassvi Aaharam ↓ (BULLISH)▲
Acquired 100% of Funk Foods via a share swap (no cash outflow) at a valuation of ₹51.16 Cr. Funk Foods' revenue grew 366% YoY (from ₹1.71 Cr to ₹7.97 Cr), indicating strong operational momentum. The non-cash structure preserves Tejassvi's liquidity.
- Siyaram Silk Mills ↓ (BULLISH)▲
NCLT sanctioned a scheme to issue bonus preference shares (4 Series I + 3 Series II for every 1 equity share), utilizing surplus reserves. This is a shareholder-friendly capital allocation move that rewards investors without a cash dividend outflow.
- Emcure Pharmaceuticals ↓ (NEUTRAL)▲
Completed the acquisition of the remaining 12.05% stake in Gennova Biopharmaceuticals for ₹231.87 Cr, making it a wholly-owned subsidiary. Gennova's revenue grew 14.4% YoY to ₹4,917.42 Mn, but its PAT margin is a thin 1.1%, suggesting the acquisition is more about strategic control than immediate profitability.
- Crest Ventures ↓ (BULLISH)▲
Received 'no adverse observations' from BSE/NSE for its scheme with Crest Capital, a key regulatory milestone. The observation letter is valid for 6 months, providing a clear timeline for NCLT filing. This unlocks value by creating a separate listed entity.
- RRIL Limited ↓ (BULLISH)▲
Increased stake in Sumati Spintex to 75% (from 50%), making it a subsidiary. This consolidation move signals management's confidence in the subsidiary's prospects and allows for full operational control.
- Godrej Consumer Products ↓ (NEUTRAL)▲
Invested ₹200 Cr in Godrej Pet Care via a rights issue. While the parent's commitment is strong, the subsidiary's revenue is volatile (declined 37% in FY25 before recovering to ₹222.1 Lakh in FY26), making this a high-risk, long-term bet.
- Inox Green Energy Services ↓ (BULLISH)▲
Fixed record date (Aug 1, 2026) for demerger with Inox Renewable Solutions. Shareholders receive 122 IRSL shares for every 1,000 Inox Green shares, creating a pure-play renewable energy entity and unlocking value.
- Rubicon Research (US Facility) (NEUTRAL)▲
Acquired a US manufacturing facility for USD 2.9 Mn via bankruptcy auction. This provides a low-cost entry into the US market, though the site has a Form 483 with 6 observations. Management expects to start manufacturing in CY2027, making this a medium-term catalyst.
Risk Flags (9)
- Tejassvi Aaharam/Valuation Risk↓ [HIGH RISK]▼
The acquisition of Funk Foods for ₹51.16 Cr is at a very high multiple (6.4x FY25 revenue of ₹7.97 Cr). While growth is strong, the absolute revenue is small, and the share swap structure could dilute existing shareholders if Funk Foods fails to sustain its growth trajectory.
- United Spirits/Nuvola Spirits↓ [HIGH RISK]▼
The investee has a negative net worth of INR -0.15 Cr as of March 2025, indicating it is burning cash. The investment is a high-risk venture capital-style bet on a startup with no proven profitability.
- Godrej Pet Care/Volatility Risk [HIGH RISK]▼
The subsidiary's revenue is highly volatile (₹73.11 Lakh in FY24, ₹46.33 Lakh in FY25, ₹222.1 Lakh in FY26). The ₹200 Cr investment (90x FY26 revenue) is a massive bet on an unproven category, with no clear path to profitability.
- Rubicon Research (US Facility)/Regulatory Risk [MEDIUM RISK]▼
The acquired facility received a Form 483 with 6 observations during a May 2026 USFDA inspection. While management expects resolution, any failure to address these could delay the start of manufacturing (planned for CY2027) and impair the investment.
- Emcure Pharmaceuticals/Margin Risk↓ [MEDIUM RISK]▼
Gennova's PAT margin is only 1.1% despite 14.4% revenue growth. The high acquisition cost (₹231.87 Cr for 12.05% stake, implying a valuation of ~₹1,924 Cr) could weigh on Emcure's consolidated margins if Gennova's profitability does not improve.
- Crest Ventures/Regulatory Hurdles↓ [MEDIUM RISK]▼
The scheme is subject to 20 specific observations/conditions from SEBI, including ongoing adjudication and recovery proceedings. Any failure to comply could derail the scheme or delay the listing of CCIL's shares.
- Ventura Guaranty/Execution Risk↓ [LOW RISK]▼
The amalgamation of VASPL with VSL is a compliance-driven merger with no disclosed financial benefits. The lack of financial details makes it difficult to assess the cost savings or strategic rationale.
- Rubicon Research (Kia Health Merger)/No Financial Impact [LOW RISK]▼
The merger of a wholly owned subsidiary with no share issuance or consideration is a purely administrative exercise. It provides no immediate financial benefit or catalyst for shareholders.
- Siyaram Silk Mills/Dilution of Control↓ [LOW RISK]▼
While the bonus preference shares are a reward, they increase the company's preference share capital, which could have implications for future dividend policies or capital structure.
Opportunities (9)
- Samvardhana Motherson/Yutaka Giken↓ (OPPORTUNITY)◆
The acquisition provides Motherson with access to Yutaka's technology and customer base (including Honda). With the deal closed, the focus shifts to integration and synergy realization. Investors should watch for margin improvement and revenue contribution in the next 2-3 quarters.
- United Spirits/Nuvola Spirits↓ (OPPORTUNITY)◆
USL's right to acquire remaining shares upon milestone achievement creates a potential high-return exit. If Nuvola's brands (Mikiamo, Seoulmate) gain traction in the premium craft segment, USL could acquire a fast-growing business at a pre-agreed valuation.
- Tejassvi Aaharam/Funk Foods↓ (OPPORTUNITY)◆
Funk Foods' 366% YoY revenue growth in the freeze-dried food segment is a high-growth niche. If the company can scale its operations, the share swap acquisition could prove highly accretive. Investors should monitor quarterly revenue disclosures for Funk Foods.
- Inox Green Energy Services/Demerger↓ (OPPORTUNITY)◆
The record date of Aug 1, 2026, for the demerger creates a near-term catalyst. Shareholders will receive shares in a pure-play renewable energy company (IRSL), which could command a higher valuation multiple than the combined entity.
- Crest Ventures/Scheme of Arrangement↓ (OPPORTUNITY)◆
The receipt of 'no adverse observations' from exchanges is a major step. The scheme will create a separate listed entity (CCIL), unlocking value for shareholders. The 6-month validity for NCLT filing provides a clear timeline.
- Siyaram Silk Mills/Bonus Preference Shares↓ (OPPORTUNITY)◆
The NCLT-sanctioned scheme is a rare and shareholder-friendly move. The issuance of bonus preference shares provides a steady income stream (if dividends are declared) without diluting equity. This could attract income-focused investors.
- RRIL Limited/Sumati Spintex↓ (OPPORTUNITY)◆
Increasing stake to 75% gives RRIL full control and the ability to consolidate Sumati Spintex's financials. If Sumati Spintex is profitable, this could immediately boost RRIL's earnings per share.
- Rubicon Research (US Facility)/Low-Cost Entry (OPPORTUNITY)◆
The acquisition of a USFDA-inspected facility for USD 2.9 Mn via a bankruptcy auction is a low-cost entry into the US market. The facility's proximity to Rubicon's distribution center (AimRx) provides operational synergies. If the Form 483 issues are resolved, this could be a significant value creator by CY2027.
- Emcure Pharmaceuticals/Gennova↓ (OPPORTUNITY)◆
Making Gennova a wholly-owned subsidiary allows Emcure to fully capture the benefits of Gennova's growth in the biopharmaceuticals space. Gennova's 14.4% revenue growth indicates a healthy pipeline.
Sector Themes (6)
- Premiumization in Consumer Staples◆
Two filings (United Spirits' investment in Nuvola and Godrej Pet Care's rights issue) highlight a shift towards premium, niche categories. USL is targeting the craft beverage segment, while GCPL is betting on pet care. Both are high-growth but high-risk areas, reflecting a broader industry trend of diversifying into premium adjacencies.
- Non-Cash Deal Structures Gaining Traction◆
Tejassvi Aaharam's share swap acquisition and Siyaram Silk's bonus preference share issuance demonstrate a preference for non-cash transactions. This trend allows companies to preserve cash for operations while still pursuing growth or rewarding shareholders, particularly in a high-interest-rate environment.
- Cross-Border M&A for Technology and Market Access◆
Samvardhana Motherson's acquisition of Yutaka Giken (Japan) and Rubicon Research's US facility acquisition highlight Indian companies' appetite for overseas assets. These deals are driven by the need for advanced technology (Motherson) and direct market access (Rubicon), rather than just financial returns.
- Regulatory Milestones as Key Catalysts◆
Multiple filings (Crest Ventures, Siyaram Silk, Inox Green) are at critical regulatory junctures (NCLT approval, exchange observations, record dates). These events serve as near-term catalysts that can unlock shareholder value, making them key focus points for event-driven investors.
- Consolidation of Subsidiaries for Control◆
Emcure (buying out minority in Gennova) and RRIL (increasing stake to 75% in Sumati Spintex) are examples of companies consolidating their holdings in subsidiaries. This trend suggests management sees value in full ownership, allowing for streamlined operations and full profit consolidation.
- Internal Restructuring for Compliance and Efficiency◆
Ventura Guaranty's amalgamation and Rubicon's merger of its wholly-owned subsidiary are compliance-driven or administrative moves. While not value-creating in themselves, they indicate a focus on simplifying corporate structures, which can reduce costs and improve governance over the long term.
Watch List (8)
-
Record date of Aug 1, 2026, for demerger. Watch for the listing of IRSL shares and any price discovery post-demerger. This is a near-term event with potential for value unlocking.
-
Must file the scheme with NCLT within 6 months (by Jan 20, 2027). Watch for any updates on adjudication proceedings and the timeline for NCLT approval. The listing of CCIL shares is a key catalyst.
-
Monitor Nuvola's quarterly sales growth and any news on milestone achievements that could trigger USL's option to acquire remaining shares. The startup's ability to scale will determine the success of this investment.
- Rubicon Research (US Facility)👁
Watch for updates on the resolution of the Form 483 observations and the timeline for commencing manufacturing (expected CY2027). Any USFDA action will be a critical event.
-
Post-acquisition integration of Yutaka Giken. Watch for Q2 and Q3 FY2026-27 results to see revenue and margin contribution from the acquisition. Any synergy announcements will be positive.
- Godrej Pet Care👁
Monitor the subsidiary's revenue trajectory and any announcements regarding product launches or market expansion. The ₹200 Cr investment is a long-term bet, so early signs of traction are crucial.
-
Watch for the first consolidated financial results post-acquisition of Funk Foods. The market will be looking for evidence that Funk Foods' high growth rate is sustainable.
-
Monitor the listing and trading of the new preference shares. Any announcement regarding dividend on these preference shares will be a key catalyst for income investors.
Filing Analyses
(13)
22-07-2026
Tejassvi Aaharam Limited has acquired 100% of Funk Foods Private Limited (FFPL) via a share swap, issuing 5,11,62,204 equity shares at ₹10 each (at par, no premium) for a total consideration of ₹51,16,22,040 (₹51.16 Cr). FFPL, a freeze-dried food manufacturer, reported a turnover of ₹7.97 Cr for FY2025, a sharp increase from ₹1.71 Cr in FY2024 and ₹0.22 Cr in FY2023, indicating strong growth. However, the acquisition is entirely non-cash and involves no immediate cash outflow, and FFPL's absolute turnover remains modest relative to the consideration.
- · FFPL was incorporated on 28/01/2022 and has presence only in India.
- · The acquisition is not a related party transaction; promoters/promoter group have no interest in FFPL.
- · Appropriate approvals have been obtained from shareholders via postal ballot and from BSE Limited (in-principle approval for issue and allotment).
- · A valuation report from a registered valuer has been obtained and uploaded on the company's website.
- · FFPL's authorised share capital is ₹36,00,00,000 divided into 36,00,000 equity shares of ₹100 each.
22-07-2026
The National Company Law Tribunal (NCLT), Mumbai Bench, has sanctioned a Scheme of Arrangement for Siyaram Silk Mills Limited to issue preference shares by way of bonus to its equity shareholders. Under the scheme, shareholders will receive 4 Preference Shares (Series I) and 3 Preference Shares (Series II), each of face value ₹10, fully paid up, for every 1 equity share of ₹2 held. The scheme utilizes the company's substantial surplus general reserves to reward shareholders while maintaining sufficient liquidity for business needs and creditor obligations.
- · The NCLT order was pronounced on July 21, 2026, and the company disclosed it on July 22, 2026.
- · The scheme was approved unanimously by the Board of Directors on October 26, 2024.
- · Meetings of equity shareholders and unsecured creditors were held on December 29, 2025, and the scheme was approved with the requisite majority.
- · The meeting of secured creditors was dispensed with based on their consent affidavits.
- · The company has received observation letters from BSE (dated July 11, 2025) and NSE (dated July 7, 2025) under Regulation 37 of SEBI LODR.
- · The Regional Director (WR), MCA, filed a report on April 15, 2026, with observations, all of which were addressed by the company.
- · No inquiry, inspection, investigation, or prosecution is pending against the company under the Companies Act, 2013.
- · The company's financial statements are filed up to March 31, 2025.
22-07-2026
Ventura Guaranty Ltd. disclosed that the National Company Law Tribunal (NCLT), Mumbai Bench, has sanctioned the amalgamation of its step-down subsidiary Ventura Allied Services Private Limited (VASPL) with its subsidiary Ventura Securities Limited (VSL), with an appointed date of April 1, 2024. The merger aims to simplify the group structure, reduce administrative costs, and improve financial flexibility, though no financial figures or performance metrics were provided in the filing.
- · VASPL is a wholly owned subsidiary of VSL, and both are under the same management.
- · The merger is driven by compliance with Rule 8(1)(f) and 8(3)(f) of the Securities Contracts (Regulation) Rules, 1957, requiring delinking of investment in the wholly owned subsidiary not related to securities/commodity derivatives business.
- · All shareholders and unsecured creditors of VASPL provided consent affidavits, dispensing with meetings.
- · Meetings of equity shareholders, secured creditors, and unsecured creditors of VSL were held on September 12, 2025, and the scheme was approved with requisite majority without modification.
- · The NCLT order was pronounced on July 21, 2026, and the petition was admitted on October 16, 2025.
- · VASPL currently earns lease rental income from leasing office property to VSL and other group companies.
22-07-2026
Emcure Pharmaceuticals has completed the acquisition of the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals for an aggregate cash consideration of ₹2,318.7 Million, making Gennova a wholly-owned subsidiary. The 663,865 equity shares were acquired from individual shareholders and credited to Emcure's demat account on July 21, 2026. Gennova reported a turnover of ₹4,917.42 Million and a PAT of ₹54.25 Million for FY2025-26, showing revenue growth of 14.4% YoY but a very thin profit margin of approximately 1.1%.
- · Gennova was originally incorporated as 'Emcure Dragon Biotech Limited' on June 19, 2001, and renamed to its current name on February 15, 2006.
- · The transaction is classified as a related party transaction as Emcure already held 87.95% of Gennova, and a Promoter/Director of Emcure is also a Director of Gennova.
- · The acquisition was completed ahead of the indicative deadline of July 31, 2026.
- · Gennova's PAT for FY2025-26 was only ₹54.25 Million, representing a net profit margin of approximately 1.1% on turnover of ₹4,917.42 Million.
22-07-2026
Godrej Consumer Products Limited (GCPL) has invested ₹200 Crore in its wholly-owned subsidiary Godrej Pet Care Limited via a rights issue to fund the subsidiary's business operations, growth plans, and capital requirements. The investment, completed on July 22, 2026, reinforces GCPL's commitment to the pet care category, a strategic growth area. However, Godrej Pet Care's revenue remains very small at ₹222.1 Lakh for FY26, and its revenue declined sharply from ₹73.11 Lakh in FY24 to ₹46.33 Lakh in FY25 before recovering, indicating early-stage volatility.
- · Godrej Pet Care was incorporated on January 4, 2022, originally as Godrej Consumer Care Limited, and renamed to Godrej Pet Care Limited effective October 28, 2024.
- · The investment was made at a premium of ₹114 per share on a rights basis, with a face value of ₹10 per share.
- · The transaction is a related-party transaction (subsidiary) but conducted at arm's length; promoter/promoter group/group companies have no interest in Godrej Pet Care except through GCPL's shareholding.
- · No governmental or regulatory approvals were required for the investment.
- · The investment is a primary capital infusion, not a secondary purchase/sale.
22-07-2026
Inox Green Energy Services Limited has fixed August 1, 2026 as the record date for its demerger scheme with Inox Renewable Solutions Limited (IRSL). Eligible shareholders will receive 122 equity shares of IRSL for every 1,000 shares held in Inox Green Energy Services. The company confirms no outstanding warrants exist, making the warrant exchange ratio inapplicable.
- · Record date is Saturday, 1st August 2026.
- · Face value of both Inox Green and IRSL equity shares is Rs. 10 each.
- · No outstanding warrants exist as of the filing date.
22-07-2026
Rubicon Research Limited has filed a Scheme of Merger for its wholly owned subsidiary, Kia Health Tech Private Limited, with itself under Section 233 of the Companies Act, 2013. The merger, approved by the Board on July 20, 2026, with an appointed date of April 1, 2026, aims to achieve business synergies, eliminate duplicate work, and reduce regulatory compliances. No financial figures, share issuance, or consideration are involved, and the scheme is exempt from prior stock exchange approval as it solely involves a wholly owned subsidiary merger.
- · The appointed date for the merger is April 1, 2026.
- · The scheme is filed under Section 233 of the Companies Act, 2013, and is exempt from prior stock exchange approval under SEBI Master Circular dated June 20, 2023.
- · No shares will be issued and no consideration will be paid as part of this merger.
- · Kia Health Tech Private Limited was originally incorporated as KIA Biopharma Technologies Private Limited in July 2021 and renamed in January 2022.
- · The merger is intended to optimize resources, reduce overheads, and improve cash management efficiency.
22-07-2026
Crest Ventures Limited (CVL) has received observation letters from BSE and NSE with 'no adverse observations' and 'no objection' respectively regarding its proposed scheme of arrangement with Crest Capital and Investment Limited (CCIL). The exchanges have outlined several conditions, including disclosure of ongoing adjudication and recovery proceedings, compliance with SEBI circulars, and ensuring that financials in the scheme are not more than 6 months old. The listing of CCIL's equity shares is subject to SEBI granting relaxation under Rule 19(2)(b) of the SCRR and compliance with other requirements. The observation letter is valid for six months from July 20, 2026, within which the scheme must be submitted to the NCLT.
- · The observation letter from BSE is dated July 20, 2026, and is valid for six months (until approximately January 20, 2027) for filing the scheme with NCLT.
- · SEBI provided comments on the draft scheme via a letter dated May 29, 2026, including 20 specific observations/conditions.
- · The listing of CCIL's equity shares is subject to SEBI granting relaxation under Rule 19(2)(b) of the Securities Contract (Regulation) Rules, 1957.
- · The scheme includes a condition that shares allotted pursuant to the scheme shall remain frozen in the depository system until listing/trading permission is given by the designated stock exchange.
- · There shall be no change in the shareholding pattern of CCIL between the record date and the listing which may affect the status of this approval.
22-07-2026
United Spirits Limited (USL) has approved an investment of INR 2.69 crore in Nuvola Spirits Private Limited (NSPL) for a 10.08% stake on a fully diluted basis. NSPL, founded in 2023, sells craft liqueur brands Mikiamo and Seoulmate, with unaudited FY25-26 sales of INR 3.50 crore. The investment aligns with USL's strategy to back innovative founders in the premium craft beverage segment.
- · NSPL was incorporated on 2nd August 2023.
- · NSPL had zero sales in FY 23-24.
- · USL has the right to appoint one director and an observer to NSPL's board.
- · The definitive agreements include an option for USL to acquire remaining shares upon achieving milestones.
- · The transaction is not a related party transaction.
22-07-2026
United Spirits Limited (USL) has approved an investment of INR 2.69 crore in Nuvola Spirits Private Limited (NSPL) for a 10.08% stake on a fully diluted basis. NSPL, founded in 2023, has rapidly growing revenue from INR 0.38 crore in FY25 to INR 3.50 crore (unaudited) in FY26, though its net worth was negative INR 0.15 crore as of March 2025. The investment aligns with USL's strategy to back innovative founders in the premium craft beverage segment.
- · NSPL was incorporated on 2nd August 2023.
- · USL has the right to appoint one director and an observer to NSPL's board.
- · The definitive agreements provide an option for USL to acquire remaining shares upon NSPL achieving pre-agreed milestones.
- · The transaction is not a related party transaction.
- · Completion expected on or before 21st September 2026.
22-07-2026
RRIL LIMITED has completed an additional acquisition of 2,87,500 equity shares of Sumati Spintex Private Limited at Rs.10 each, representing an additional 25% stake, increasing its total holding to 75%. As a result, Sumati Spintex Private Limited will become a subsidiary of RRIL LIMITED.
- · The acquisition was completed on July 22, 2026, following a prior disclosure on July 21, 2026.
- · The shares were purchased from existing shareholders of Sumati Spintex Private Limited.
- · The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- · The information has been disseminated on the company's website at www.rrillimited.com.
22-07-2026
Rubicon Research Limited, through its wholly owned US subsidiary AdvaGen Holdings Inc., has acquired a manufacturing facility in East Brunswick, New Jersey from InvaTech Pharma Solutions, LLC for an enterprise value of USD 2.9 million. The facility, which manufactures oral solid and oral liquid formulations, was acquired via a court-supervised bankruptcy auction under Section 363 of the U.S. Bankruptcy Code. While the acquisition provides Rubicon with a US manufacturing footprint comparable to its Satara facility, it does not include any product approvals or filings, and the site received a Form 483 with 6 observations during a May 2026 USFDA inspection, though management expects the inspection to be successfully concluded.
- · The facility shares a wall with Rubicon's US distribution center operated by subsidiary AimRx.
- · Rubicon expects to commence manufacturing at the site in calendar year 2027 after implementing its quality management systems.
- · The site has been USFDA inspected for over a decade with 3 successful inspections.
- · The Form 483 observations were largely procedural and unrelated to data integrity.
- · Rubicon will make significant capital investments over the next 3 years to expand manufacturing capabilities at the facility.
22-07-2026
Samvardhana Motherson International Limited, through its indirect wholly owned subsidiary Motherson Global Investments B.V. (MGI BV), has completed the acquisition of an 81% stake in Yutaka Giken Co., Ltd. (YGCL) and an 11% stake in Shinnichi Kogyo Co., Ltd. The final closing of the transaction occurred on July 21, 2026, following a share buyback by YGCL from Honda Motor Co., Ltd. Post-acquisition, YGCL's shareholding is 81% held by MGI BV and 19% held by Honda Motor.
- · The acquisition was initially disclosed on August 29, 2025.
- · The time period for completion was previously mentioned as Q2 FY2026-2027 in a June 30, 2026 disclosure.
- · A status update regarding receipt of Voluntary Sale Permission Decision from the competent court was provided on July 17, 2026.
- · YGCL was listed on the Tokyo Stock Exchange.
- · The definitive agreements required YGCL to complete a buyback of shares held by Honda Motor Co., Ltd. before final closing.
Get daily alerts with 10 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 13 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Merger Acquisition MCA Regulatory Filings
July 20, 2026
India Merger Acquisition MCA Regulatory Filings — July 20, 2026
July 19, 2026
India Merger Acquisition MCA Regulatory Filings — July 19, 2026
July 18, 2026
India Merger Acquisition MCA Regulatory Filings — July 18, 2026
July 17, 2026
India Merger Acquisition MCA Regulatory Filings — July 17, 2026
🇮🇳 More from India
View all →July 22, 2026
India Pre-Market Regulatory Roundup — July 22, 2026
India Pre-Market Regulatory Roundup
July 22, 2026
India Quarterly Results BSE NSE Announcements — July 22, 2026
India Quarterly Results BSE NSE Announcements
July 22, 2026
India Upcoming Corporate Actions BSE NSE — July 22, 2026
India Upcoming Corporate Actions BSE NSE
July 22, 2026
India MCA Corporate Compliance Enforcement — July 22, 2026
India MCA Corporate Compliance Enforcement